KALA BIO, Inc. — Director's Dealing 2025

Mar 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KALA BIO, Inc. (KALA)
CIK: 0001479419
Period of Report: 2025-03-07

Reporting Person: Bazemore Todd (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-07	Stock Option (right to buy)	$7.05	A	45200	Acquired	2035-03-06	Common Stock (45200)	Direct

Footnotes

F1: This option was granted on March 7, 2025 and vests as to 1/12th of the shares underlying the option at the end of each successive one-month period over a one-year period following February 11, 2025, subject to the Reporting Person's continued employment with the Issuer.